• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

麦加医院登革热发热患者登革热血清型的估计与特征分析

Estimation and Characterization of Dengue Serotypes in Patients Presenting with Dengue Fever at Makkah Hospitals.

作者信息

Melebari Sami, Hafiz Abdul, Natto Hatim A, Elamin Mohamed Osman, Jalal Naif A, Hakim Ashwaq, Rushan Safiah, Fallatah Othman, Alzabeedi Kamal, Malibari Feras, Mashat Hutaf, Alsaadi Aisha, Alhakam Amani, Hadidi Anoud, Alkhaldi Ghazi Saad, Alkhyami Ahmed, Alqarni Ali, Alzahrani Abdulaziz, Alghamdi Mohammed, Siddiqi Abdullah, Alasmari Abdullah, Bakri Rowaida, Alqahtani Saleh, Al-Bajaly Juman M, Khogeer Asim

机构信息

Department of Molecular Biology, The Regional Laboratory, Ministry of Health, Makkah 21955, Saudi Arabia.

Department of Microbiology and Parasitology, Faculty of Medicine, Umm Al-Qura University, Makkah 21955, Saudi Arabia.

出版信息

Trop Med Infect Dis. 2025 Jan 20;10(1):27. doi: 10.3390/tropicalmed10010027.

DOI:10.3390/tropicalmed10010027
PMID:39852678
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC11769056/
Abstract

Dengue fever is caused by four common serotypes of the dengue virus (DENV-1, DENV-2, DENV-3, and DENV-4). Patients infected with one serotype may develop lifelong serotype-specific protective immunity. However, they remain susceptible to reinfection with the other serotypes, often increasing the risk of severe forms of dengue. This cross-sectional study investigates the prevalence of the four dengue serotypes in patients who presented with dengue fever at Makkah hospitals between April 2023 and May 2024. Data were collected from the medical records of the Regional Laboratory in Makkah, Saudi Arabia. The 238 positive dengue samples included 185 samples (77.73%) from male patients. The average age of the patients was 37.65 years (SD = 15.05). Dengue type 2 was the most common serotype, followed by type 1, type 3, and type 4. Most of the dengue patients were Saudi nationals, followed by Egyptians. There were 11 dengue-positive samples that were not diagnosed with any of the four dengue serotypes. Since Makkah receives numerous international travelers, these samples might contain novel dengue serotypes circulating in different parts of the world. This study underscores the need for the continuous monitoring of dengue serotypes to predict potential outbreaks and mitigate the risk of severe dengue in susceptible populations.

摘要

登革热由四种常见的登革病毒血清型(DENV-1、DENV-2、DENV-3和DENV-4)引起。感染一种血清型的患者可能会产生终身的血清型特异性保护性免疫。然而,他们仍然易受其他血清型的再次感染,这往往会增加患严重登革热的风险。这项横断面研究调查了2023年4月至2024年5月期间在麦加医院出现登革热症状的患者中四种登革热血清型的流行情况。数据从沙特阿拉伯麦加地区实验室的病历中收集。238份登革热阳性样本中,有185份(77.73%)来自男性患者。患者的平均年龄为37.65岁(标准差 = 15.05)。登革热2型是最常见的血清型,其次是1型、3型和4型。大多数登革热患者是沙特公民,其次是埃及人。有11份登革热阳性样本未被诊断出感染四种登革热血清型中的任何一种。由于麦加接待大量国际旅行者,这些样本可能包含在世界不同地区传播的新型登革热血清型。这项研究强调了持续监测登革热血清型以预测潜在疫情并降低易感人群中严重登革热风险的必要性。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/dda7/11769056/b766abd8b11d/tropicalmed-10-00027-g001.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/dda7/11769056/b766abd8b11d/tropicalmed-10-00027-g001.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/dda7/11769056/b766abd8b11d/tropicalmed-10-00027-g001.jpg

相似文献

1
Estimation and Characterization of Dengue Serotypes in Patients Presenting with Dengue Fever at Makkah Hospitals.麦加医院登革热发热患者登革热血清型的估计与特征分析
Trop Med Infect Dis. 2025 Jan 20;10(1):27. doi: 10.3390/tropicalmed10010027.
2
Circulation of Dengue Virus Serotypes in the City of Makkah, Saudi Arabia, as Determined by Reverse Transcription Polymerase Chain Reaction.沙特阿拉伯麦加市登革病毒血清型的循环情况,通过逆转录聚合酶链反应确定
Can J Infect Dis Med Microbiol. 2017;2017:1646701. doi: 10.1155/2017/1646701. Epub 2017 Feb 19.
3
CD8+ T Cells Can Mediate Short-Term Protection against Heterotypic Dengue Virus Reinfection in Mice.CD8 + T细胞可介导小鼠对异型登革病毒再感染的短期保护。
J Virol. 2015 Jun;89(12):6494-505. doi: 10.1128/JVI.00036-15. Epub 2015 Apr 8.
4
Detection of Dengue Virus From (Diptera, Culicidae) in Field-Caught Samples From Makkah Al-Mokarramah, Kingdom of Saudi Arabia, Using RT-PCR.沙特阿拉伯麦加,利用 RT-PCR 从野外捕获的样本中检测登革热病毒(双翅目,蚊科)
Front Public Health. 2022 Jun 9;10:850851. doi: 10.3389/fpubh.2022.850851. eCollection 2022.
5
Episodes of the epidemiological factors correlated with prevailing viral infections with dengue virus and molecular characterization of serotype-specific dengue virus circulation in eastern India.与登革热病毒相关的流行病毒感染的流行病学因素以及印度东部血清型特异性登革热病毒循环的分子特征。
Infect Genet Evol. 2018 Mar;58:40-49. doi: 10.1016/j.meegid.2017.12.005. Epub 2017 Dec 13.
6
The prevalence of dengue virus serotypes in asymptomatic blood donors reveals the emergence of serotype 4 in Saudi Arabia.无症状献血者中登革病毒血清型的流行情况显示沙特阿拉伯出现了4型血清型。
Virol J. 2017 Jun 9;14(1):107. doi: 10.1186/s12985-017-0768-7.
7
Emergence of dengue virus type 1 and type 3 as dominant serotypes during 2017 in Pune and Nashik regions of Maharashtra, Western India.2017 年在印度西部马哈拉施特拉邦浦那和纳西克地区,登革热病毒 1 型和 3 型成为主要流行血清型。
Infect Genet Evol. 2018 Dec;66:272-283. doi: 10.1016/j.meegid.2018.10.016. Epub 2018 Oct 23.
8
Molecular surveillance for dengue serotypes among the population living in Moyen-Ogooué province, Gabon; evidence of the presence of dengue serotype 1.在加蓬中奥果韦省居住的人群中对登革热血清型进行分子监测;存在登革热血清型 1 的证据。
Virol J. 2024 Jun 20;21(1):141. doi: 10.1186/s12985-024-02406-x.
9
Circulating serotypes of dengue virus and their incursion into non-endemic areas of Pakistan; a serious threat.登革热病毒的循环血清型及其侵入巴基斯坦非流行地区;一个严重威胁。
Virol J. 2016 Aug 26;13(1):144. doi: 10.1186/s12985-016-0603-6.
10
Clinical profile and outcome of hospitalized patients during first outbreak of dengue in Makkah, Saudi Arabia.沙特阿拉伯麦加首次登革热疫情期间住院患者的临床特征与结局
Acta Trop. 2008 Jan;105(1):39-44. doi: 10.1016/j.actatropica.2007.09.005. Epub 2007 Sep 29.

本文引用的文献

1
The World Health Organization's declaration of Egypt as malaria free will boost malaria control efforts in the region.世界卫生组织宣布埃及已无疟疾,这将推动该地区的疟疾防治工作。
New Microbes New Infect. 2024 Nov 6;62:101529. doi: 10.1016/j.nmni.2024.101529. eCollection 2024 Dec.
2
Global landmark: 2023 marks the worst year for dengue cases with millions infected and thousands of deaths reported.全球标志性事件:2023年是登革热病例最严重的一年,报告称数百万人感染,数千人死亡。
IJID Reg. 2024 Sep 26;13:100459. doi: 10.1016/j.ijregi.2024.100459. eCollection 2024 Dec.
3
Malaria during COVID-19 Travel Restrictions in Makkah, Saudi Arabia.
沙特阿拉伯麦加在新冠疫情旅行限制期间的疟疾情况。
Trop Med Infect Dis. 2024 May 15;9(5):112. doi: 10.3390/tropicalmed9050112.
4
Genetic variants associated with dengue hemorrhagic fever. A systematic review and meta-analysis.与登革出血热相关的遗传变异。系统评价和荟萃分析。
J Infect Public Health. 2024 Apr;17(4):579-587. doi: 10.1016/j.jiph.2024.02.001. Epub 2024 Feb 3.
5
Challenges on the development of a dengue vaccine: a comprehensive review of the state of the art.登革热疫苗研发面临的挑战:技术现状全面综述。
J Gen Virol. 2023 Mar;104(3). doi: 10.1099/jgv.0.001831.
6
Spatio-temporal dynamics of dengue-related deaths and associated factors.登革热相关死亡的时空动态及其相关因素。
Rev Inst Med Trop Sao Paulo. 2022 Apr 4;64:e30. doi: 10.1590/S1678-9946202264030. eCollection 2022.
7
The epidemiology and incidence of dengue in Makkah, Saudi Arabia, during 2017-2019.2017-2019 年沙特麦加登革热的流行病学和发病率。
Saudi Med J. 2021 Nov;42(11):1173-1179. doi: 10.15537/smj.2021.42.11.20210124.
8
Dengue Vaccines: Ongoing Challenges and Current Status in the Advancement of Different Candidates.登革热疫苗:不同候选疫苗的进展中面临的持续挑战和现状。
Crit Rev Eukaryot Gene Expr. 2021;31(5):7-19. doi: 10.1615/CritRevEukaryotGeneExpr.2021038839.
9
Dengue and human health: A global scenario of its occurrence, diagnosis and therapeutics.登革热与人类健康:其全球发病、诊断及治疗情况概述
Saudi J Biol Sci. 2021 Sep;28(9):5074-5080. doi: 10.1016/j.sjbs.2021.05.023. Epub 2021 May 20.
10
Perception of the health surveillance users on the health electronic surveillance network (HESN), Saudi Arabia, 2016.2016年沙特阿拉伯健康电子监测网络(HESN)健康监测用户的认知情况
J Egypt Public Health Assoc. 2021 Jun 16;96(1):17. doi: 10.1186/s42506-021-00074-1.